Improving social network support for partners facing spousal cancer while caring for minors: Four-month outcomes of a single-centre randomised controlled trial.
cancer
evaluation
families
psychological
quality of life
social
Journal
European journal of cancer care
ISSN: 1365-2354
Titre abrégé: Eur J Cancer Care (Engl)
Pays: England
ID NLM: 9301979
Informations de publication
Date de publication:
Jan 2019
Jan 2019
Historique:
received:
01
01
2018
revised:
21
06
2018
accepted:
15
07
2018
pubmed:
5
9
2018
medline:
15
5
2019
entrez:
5
9
2018
Statut:
ppublish
Résumé
Social support is an important predictor of the well-being of partners of cancer patients. Those who are caring for minors (well parents) may be in special need of such support. The aim of this study was to evaluate the 4-month impact of a psychoeducational social support intervention, named the Cancer-PEPSONE programme (CPP), on well parents' received and perceived social support, as well as on their psychological distress, quality of life (QOL) and parental capacity. The study was an open randomised controlled trial with a parallel-group design (N = 35; Intervention = 17, Controls = 18). The participants in the intervention group received CPP in their homes. Controls received support as usual. Data were collected in Norway using validated self-report questionnaires. Questionnaires were sent by post, before randomisation (T1), and at three- (T2) and six-month (T3) follow-up. Linear mixed models analyses revealed intervention effects on received (p = 0.04, d = 0.6) and perceived (p = 0.01, d = 1.0) social support, as well as on parental capacity (p = 0.02, d = 1.0), but not on psychological distress and QOL. Social support mediated the relationship between receiving CPP and later psychological distress. CPP may help well parents in maintaining social support and enhancing parental capacity. An improvement in social support may alleviate well parents' psychological distress.
Types de publication
Journal Article
Randomized Controlled Trial
Langues
eng
Pagination
e12907Subventions
Organisme : Norwegian Directorate of Health
ID : 12/9763-1
Organisme : Norges Forskningsråd
ID : 213049/H10
Informations de copyright
© 2018 John Wiley & Sons Ltd.